Pfizer Hits a New 52-Week High. Here's Why It's Not Too Late to Buy the Stock
This surprising healthcare stock has been outperforming the markets this year.
Pfizer (PFE) stock news
Every headline mentioning Pfizer from Yahoo Finance, CNBC and Nasdaq over the last 30 days, each scored for sentiment and importance. Updated automatically through the trading day.
Headlines2last 7 days · 8 in 30 days
Sentiment, 30 days
4 positive4 neutral0 negative
Latest headlineTue 10 Nov, 11:20 UTCHealthcare
Latest PFE headlines
Tuesday, 10 November 2026
Friday, 6 November 2026
Buy, Sell, or Hold? Friday’s Top Upgrades and Downgrades: Becton Dickinson, BJ’s Wholesale Club, Cogent Communications, Fervo Energy, JinkoSolar, Molson-Coors, Pfizer, SiTime, Steven Madden, and More
After a brutal sell-off erased Wednesday's rally and dragged the Nasdaq back into correction territory, Wall Street analysts are still moving. Some reversed course on Pfizer, Molson Coors, and BJ's, while others spotted fresh…
Wednesday, 4 November 2026
Pfizer Inc. Appoints Cecile Guegan as Chief Financial Officer
Pfizer Inc. announced that its Board of Directors unanimously elected Cecile Guegan to serve as Chief Financial Officer, Executive Vice President of the Company, effective November 1, 2026. Ms. Guegan, 55, was previously appointed as…
Tuesday, 3 November 2026
Pfizer hikes full-year outlook on new product growth, taps company veteran as new CFO
Pfizer announced that Cecile Guegan, who has held various leadership roles at the company over the last 20 years, stepped in as CFO this month.
Pfizer CEO Touts $80 Billion In Deals — But 'The Real Test' Is Still Ahead
Pfizer beat third-quarter expectations and hiked its guidance Tuesday, but a portfolio manager says "the real test (is) still ahead."
Stocks making the biggest moves premarket: Pfizer, Apple, Palantir, Zebra Technologies & more
These are the stocks posting the largest moves premarket.
Thursday, 29 October 2026
Looking for income? These dividend stocks have high yields that seem well supported.
Ford, Pfizer and Verizon are among 11 stocks that passed a screen of the S&P 500 for high dividend yields that are expected to be well covered by the companies’ free cash flow.
Thursday, 15 October 2026
Moderna Rallies 6% as Money Rotates Into Healthcare; BioNTech and Pfizer Edge Higher
Money is leaving the AI trade and landing in healthcare, but one mRNA name is surging at a pace that leaves its closest peers far behind, and a clinical story from weeks ago may explain why.